Track topics on Twitter Track topics that are important to you
On April 28, 2011, the US Food and Drug Administration (FDA) approved Zytiga (abiraterone acetate), for use in combination with prednisone for the second-line treatment of castration-resistant prost...
David SalazarAppearing before the House Subcommittee on Agriculture, Rural Development, Food and Drug Administration and Related Agencies, Food and Drug administration commissioner Dr. Scott Gott...
Food and Drug Administration Commissioner Scott Gottlieb said the FDA must "take all necessary steps to reduce the scope of opioid misuse and abuse." The Food and Drug Administration shocked lawmakers...
The US Food and Drug Administration (FDA) has accepted and filed the New Drug Administration (NDA) for…
MARAWI, Philippines (AP) — There was food and water— welcome commodities amid the frequent tears. There was, finally, safety, at least for the moment. And there were stories — stories of things ...
Major drug makers in India are in a soup. It is not just the US Food and Drug Administration that is…
ARDSLEY, N.Y.--(BUSINESS WIRE) June 29, 2017 -- Acorda Therapeutics, Inc. (NASDAQ: ACOR) has submitted a New Drug Application (NDA) to the U.S. Food and Drug Administration (FDA) for Inbrija (CVT-301,...
EDMONTON, AB--(Marketwired - June 14, 2017) -Exciton Technologies has received approval from the China Food and Drug Administration (CFDA) for Exsalt®, the Company's Read more...
Scott Gottlieb to Newly Confirmed Head of the FDA & HSPH Interview with Margaret Hamburg, 21st Commissioner of the U.S. Food and Drug, 5/9/2017 Reporter: Aviva Lev-Ari, PhD, RN WATCH VIDEO...
To summarize the US Food and Drug Administration's (FDA's) review of the safety and effectiveness for pimavanserin, an atypical antipsychotic, for the treatment of hallucinations and delusions associa...
To examine the association between the 2014 U.S. Food and Drug Administration (FDA) safety communication on power morcellation and surgical approach and morbidity after myomectomy.
To evaluate the trends in mode of surgery for benign hysterectomy after the 2014 U.S. Food and Drug Administration (FDA) morcellation guidelines.
To characterize the frequency, nature, and regulatory mechanisms by which ophthalmic devices are iteratively modified after initial Food and Drug Administration (FDA) Premarket Approval (PMA).
The US Food and Drug Administration (FDA) recently issued a safety warning regarding soft-tissue fillers (STFs) based on the risk of blindness and facial necrosis.